HAX-1 promotes the chemoresistance, invasion, and tumorigenicity of esophageal squamous carcinoma cells

Dig Dis Sci. 2012 Jul;57(7):1838-46. doi: 10.1007/s10620-012-2108-5. Epub 2012 Mar 27.

Abstract

Background: HAX-1 is an anti-apoptotic factor and regulates the expression of DNA pol β. Interestingly, DNA polymerase pol β is overexpressed in esophageal squamous cell carcinoma (ESCC). However, the functional role of HAX-1 in ESCC remains unclear.

Aims: To investigate the role of HAX-1 in chemoresistance, invasion, and tumorigenicity of ESCC.

Methods: Lentivirus-mediated overexpression or knockdown of HAX-1 was employed to establish ESCC EC9706 cell lines that expressed HAX-1 at different levels. The biological behaviors of these engineered cells were characterized in vitro and in vivo using a xenograft nude mice model. In addition, HAX-1 and pol β expression in the tumor tissues was detected by RT-PCR and immunohistochemistry.

Results: HAX-1 overexpression promoted cell proliferation and resistance against cisplatin, increased cell invasion and suppressed apoptosis along with increased pol β expression. Conversely, HAX-1 knockdown inhibited the malignant phenotypes of EC9706 cells. The xenograft nude mice model demonstrated that HAX-1 overexpression or depletion led to increased or decreased tumor growth in vivo, respectively. Furthermore, a positive correlation of HAX-1 and pol β expression in the tumor tissues was observed.

Conclusions: HAX-1 promotes the proliferation, chemoresistance, invasion, and tumorigenicity of ESCC, and this is correlated with increased poly β expression. HAX-1 may represent a potential target to overcome the resistance and metastasis of ESCC.

Publication types

  • Retracted Publication

MeSH terms

  • Adaptor Proteins, Signal Transducing / drug effects
  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / physiology*
  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / physiopathology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cell Transformation, Neoplastic / pathology*
  • Cisplatin / pharmacology
  • Cisplatin / therapeutic use
  • Disease Models, Animal
  • Drug Resistance, Neoplasm / physiology*
  • Esophageal Neoplasms / drug therapy
  • Esophageal Neoplasms / pathology*
  • Esophageal Neoplasms / physiopathology*
  • Female
  • HEK293 Cells
  • Humans
  • In Vitro Techniques
  • Mice
  • Mice, Nude
  • Neoplasm Invasiveness / physiopathology
  • RNA, Small Interfering / pharmacology
  • Transplantation, Heterologous

Substances

  • Adaptor Proteins, Signal Transducing
  • Antineoplastic Agents
  • HAX1 protein, human
  • RNA, Small Interfering
  • Cisplatin